{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:46:30Z","timestamp":1792658790630,"version":"4.5.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Congenital myopathy constitutes a heterogeneous group of orphan diseases that are mainly classified on the basis of muscle biopsy findings. This study aims to estimate the prevalence of congenital myopathy through a systematic review and meta-analysis of the literature.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The PubMed, MEDLINE, Web of Science, and Cochrane Library databases were searched for original research articles published in English prior to July 30, 2021. The quality of the included studies was assessed by a checklist adapted from STrengthening the Reporting of OBservational studies in Epidemiology (STROBE). To derive the pooled epidemiological prevalence estimates, a meta-analysis was performed using the random effects model. Heterogeneity was assessed using the Cochrane <jats:italic>Q<\/jats:italic> statistic as well as the <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> statistic.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 11 studies were included in the systematic review and meta-analysis. Of the 11 studies included, 10 (90.9%) were considered medium-quality, one (9.1%) was considered low-quality, and no study was assessed as having a high overall quality. The pooled prevalence of congenital myopathy in the all-age population was 1.62 (95% CI, 1.13\u20132.11) per 100,000, while the prevalence in the child population was 2.76 (95% CI, 1.34\u20134.18) per 100,000. In the pediatric population, the prevalence among males was 2.92 (95% CI, \u22121.70 to 7.55) per 100,000, while the prevalence among females was 2.47 (95% CI, \u22121.67 to 6.61) per 100,000. The prevalence estimates of the all-age population per 100,000 were 0.20 (95% CI 0.10\u20130.35) for nemaline myopathy, 0.37 (95% CI 0.21\u20130.53) for core myopathy, 0.08 (95% CI \u22120.01 to 0.18) for centronuclear myopathy, 0.23 (95% CI 0.04\u20130.42) for congenital fiber-type disproportion myopathy, and 0.34 (95% CI, 0.24\u20130.44) for unspecified congenital myopathies. In addition, the prevalence estimates of the pediatric population per 100,000 were 0.22 (95% CI 0.03\u20130.40) for nemaline myopathy, 0.46 (95% CI 0.03\u20130.90) for core myopathy, 0.44 (95% CI 0.03\u20130.84) for centronuclear myopathy, 0.25 (95% CI \u22120.05 to 0.54) for congenital fiber-type disproportion myopathy, and 2.63 (95% CI 1.64\u20133.62) for unspecified congenital myopathies.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Accurate estimates of the prevalence of congenital myopathy are fundamental to supporting public health decision-making. The high heterogeneity and the lack of high-quality studies highlight the need to conduct higher-quality studies on orphan diseases.<\/jats:p>","DOI":"10.3389\/fneur.2021.761636","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T05:05:11Z","timestamp":1635829511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["A Systematic Review and Meta-Analysis of the Prevalence of Congenital Myopathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Kun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ncl.2014.04.006","article-title":"Congenital myopathies and muscular dystrophies","volume":"32","author":"Gilbreath","year":"2014","journal-title":"Neurol Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fneur.2019.00516","article-title":"Autoimmune channelopathies at neuromuscular junction","volume":"10","author":"Huang","year":"2019","journal-title":"Front Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/neup.12667","article-title":"Investigation of adult-onset multiple Acyl-CoA dehydrogenase deficiency associated with peripheral neuropathy","volume":"40","author":"Huang","year":"2020","journal-title":"Neuropathology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13052-017-0419-z","article-title":"Congenital myopathies: clinical phenotypes and new diagnostic tools","volume":"43","author":"Cassandrini","year":"2017","journal-title":"Ital J Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/dmcn.14365","article-title":"Congenital myopathies: an update","volume":"62","author":"Claeys","year":"2020","journal-title":"Dev Med Child Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/neup.12761","article-title":"Clinicopathological features of titinopathy from a Chinese neuromuscular center","volume":"41","author":"Huang","year":"2021","journal-title":"Neuropathology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.7499\/j.issn.1008-8830.2018.10.004","article-title":"Clinical, pathological and genetic studies of two cases of childhood-onset nemaline myopathy","volume":"20","author":"Huang","year":"2018","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi."},{"key":"B8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10974-019-09519-9","article-title":"Nemaline myopathies: a current view","volume":"40","author":"Sewry","year":"2019","journal-title":"J Muscle Res Cell Motil."},{"key":"B9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-015-1430-3","article-title":"Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function","volume":"130","author":"Sztal","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","article-title":"Core myopathies","volume":"18","author":"Jungbluth","year":"2011","journal-title":"Semin Pediatr Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"dmm041368","DOI":"10.1242\/dmm.041368","article-title":"Cored in the act: the use of models to understand core myopathies","volume":"12","author":"Fusto","year":"2019","journal-title":"Dis Model Mech."},{"key":"B12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1172-3-26","article-title":"Centronuclear (myotubular) myopathy","volume":"3","author":"Jungbluth","year":"2008","journal-title":"Orphanet J Rare Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nan.12369","article-title":"Myopathology in congenital myopathies","volume":"43","author":"Sewry","year":"2017","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/aje\/kwv158","article-title":"Epidemiology: Then and now","volume":"183","author":"Kuller","year":"2016","journal-title":"Am J Epidemiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-007-0445-9","article-title":"Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls","volume":"123","author":"Kavvoura","year":"2008","journal-title":"Hum Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2174\/1570159X18666200729092332","article-title":"Pharmacological strategy for congenital myasthenic syndrome with CHRNE mutations: a meta-analysis of case reports","volume":"19","author":"Huang","year":"2020","journal-title":"Curr Neuropharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13023-014-0173-x","article-title":"A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases","volume":"9","author":"Leadley","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis","volume":"15","author":"Crisafulli","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.22510","article-title":"Prevalence of congenital myopathies in a representative pediatric united states population","volume":"70","author":"Amburgey","year":"2011","journal-title":"Ann Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/08830738030180030201","article-title":"Prevalence of neuromuscular diseases in Chinese children: a study in southern China","volume":"18","author":"Chung","year":"2003","journal-title":"J Child Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/0960-8966(94)90038-8","article-title":"Diagnostic criteria for neuromuscular disorders: Edited by Alan E. H. Emery. Published 1994, European Neuromuscular Centre, Baarn, The Netherlands. ISBN 90 261 0719 6, 72 pp","volume":"4","author":"Dubowitz","year":"1994","journal-title":"Neuromuscular Disord."},{"key":"B24","first-page":"333","article-title":"World Federation of Neurology Research Committee Research Group on Neuromuscular Diseases","volume":"86","year":"1988","journal-title":"J Neurol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-8966(99)00055-3","article-title":"Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden","volume":"10","author":"Darin","year":"2000","journal-title":"Neuromuscul Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/mus.880020203","article-title":"Congenital hypotonia revisited","volume":"2","author":"Brooke","year":"1979","journal-title":"Muscle Nerve."},{"key":"B27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0960-8966(94)00017-4","article-title":"The prevalence of inherited neuromuscular disease in Northern Ireland","volume":"6","author":"Hughes","year":"1996","journal-title":"Neuromuscul Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/WNL.0000000000003504","article-title":"A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland","volume":"88","author":"Lefter","year":"2017","journal-title":"Neurology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awp236","article-title":"Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population","volume":"132","author":"Norwood","year":"2009","journal-title":"Brain."},{"key":"B30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.nmd.2008.11.001","article-title":"Gene table of monogenic neuromuscular disorders (nuclear genome only) Vol 19. No 1 January 2009","volume":"19","author":"Kaplan","year":"2009","journal-title":"Neuromuscul Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13023-019-1227-x","article-title":"Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region","volume":"14","author":"Pagola-Lorz","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.nmd.2017.10.005","article-title":"The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome)","volume":"27","author":"Bonne","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/currents.md.37f840ca67f5e722945ecf755f40487e","article-title":"Undiagnosed genetic muscle disease in the north of England: an in depth phenotype analysis","volume":"5","author":"Harris","year":"2013","journal-title":"PLoS Curr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.nmd.2006.05.192","article-title":"G.P.7 07 Epidemiology of neuromuscular disorders in Portugal at pediatric age","volume":"16","author":"Santos","year":"2006","journal-title":"Neuromuscular Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1399-0004.1988.tb02854.x","article-title":"Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to \u201cnon-Duchenne muscular dystrophy\u201d","volume":"34","author":"Tangsrud","year":"1988","journal-title":"Clin Genet."},{"key":"B36","first-page":"1","article-title":"Muscle disorders in childhood","volume":"16","author":"Dubowitz","year":"1978","journal-title":"Major Probl Clin Pediatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000494115","article-title":"A Nationwide, population-based prevalence study of genetic muscle disorders","volume":"52","author":"Theadom","year":"2019","journal-title":"Neuroepidemiology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1212\/NXG.0000000000000140","article-title":"Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark","volume":"3","author":"Witting","year":"2017","journal-title":"Neurol Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","article-title":"Approach to the diagnosis of congenital myopathies","volume":"24","author":"North","year":"2014","journal-title":"Neuromuscul Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.nmd.2015.10.010","article-title":"The 2016 version of the gene table of monogenic neuromuscular disorders (nuclear genome)","volume":"25","author":"Kaplan","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/B978-0-444-64076-5.00036-3","article-title":"The genetics of congenital myopathies","volume":"148","author":"Gonorazky","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1212\/WNL.0000000000001110","article-title":"Congenital myopathies: Natural history of a large pediatric cohort","volume":"84","author":"Colombo","year":"2015","journal-title":"Neurology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/14740338.2019.1614165","article-title":"Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study","volume":"18","author":"Crisafulli","year":"2019","journal-title":"Expert Opin Drug Saf."},{"key":"B44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40264-017-0592-4","article-title":"From big data to smart data for pharmacovigilance: the role of healthcare databases and other emerging sources","volume":"41","author":"Trifiro","year":"2018","journal-title":"Drug Saf."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s40264-019-00848-9","article-title":"Patient registries: an underused resource for medicines evaluation : operational proposals for increasing the use of patient registries in regulatory assessments","volume":"42","author":"Mcgettigan","year":"2019","journal-title":"Drug Saf."}],"updated-by":[{"DOI":"10.3389\/fneur.2022.857959","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000}}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.761636\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T15:27:31Z","timestamp":1644852451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.761636\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":45,"alternative-id":["10.3389\/fneur.2021.761636"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.761636","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fneur.2022.857959","asserted-by":"object"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"article-number":"761636"}}